Estrogen and progesterone signaling are important in tumorigenesis of hormone-dependent tissues, so the enhancement of these signaling activation by SRC-3 might be an important step in the development and progression of ovarian cancer, endometrial carcinoma, and cervical cancer. The gene discussed is NCOA3; the disease is endometrial carcinoma.